Strongyloidiasis presenting as duodenal obstruction in a patient infected with human T-cell lymphotropic virus type 1

Gastrointestinal Endoscopy

Volumn 74, Issue 2, 2011, Pages 439-441

  Hindy, Pierre ^a   Parvin, Russell ^a   Hanna, Kayane ^b   Gress, Frank ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b LONG ISLAND COLLEGE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; IVERMECTIN;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DUODENUM BIOPSY; DUODENUM OBSTRUCTION; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HUMAN TISSUE; MIXED INFECTION; PRIORITY JOURNAL; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; TREATMENT FAILURE;

ANIMALS; FEMALE; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INTESTINAL OBSTRUCTION; MIDDLE AGED; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

EID: 79960932282     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2010.11.035     Document Type: Article

References (8)

1. Genta RM. Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease. Rev Infect Dis 1989;11:755-67.
2. Grove DI. Strongyloidiasis in allied ex-prisoners of war in south-east Asia. Br Med J 1980;280:598-601. (Pubitemid 10174714)
3. Nakada K, Kohakura M, Komoda H, et al. High incidence of HTLV antibody in carriers of Strongyloides stercoralis. Lancet 1984;1:633.
4. Robinson RD, Lindo JF, Neva FA, et al. Immunoepidemiologic studies of Strongyloides stercoralis and human T lymphotropic virus type I infections in Jamaica. J Infect Dis 1994;169:692-6. (Pubitemid 24063027)
5. Chieffi PP, Chiattone CS, Feltrim EN, et al. Co-infection by Strongyloides stercoralis in blood donors infected with human T-cell leukemia/lymphoma virus type 1 in Sao Paulo City, Brazil. Mem Inst Oswaldo Cruz 2000;95:711-12.
6. Gotuzzo E, Terashima A, Alavarez H, et al. Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru. Am J Trop Med Hyg 1990;60:146-9.
7. Porto M, Muniz A, Oliveira J, et al. Clinical and immunological consequences of the association between HTLV-1 and strongyloidiasis. Rev Soc Bras Med Trop 2002;35:641-9. (Pubitemid 36313994)
8. Sato Y, Shiroma Y, Kiyuna S, et al. Reduced efficacy of chemotherapy might accumulate concurrent HTLV-1 infection among strongyloidiasis patients in Okinawa, Japan. Trans R Soc Trop Med Hyg 1994;88:59. (Pubitemid 24068847)